Skip to main content

JPMORGAN CHASE & CO

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 19617 NEW YORK, NY

Position in REGN

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$3,331,473,778
+$290,182,489 QoQ
Shares Held
4,311,806
+9.4% QoQ
Ownership
4.11%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 90.10795012577097.ToString("F0")% Shared 1.053340525988414.ToString("F0")% None 8.838709348240622.ToString("F0")%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JPMORGAN CHASE & CO holds $16,578,690,346 across 405 Biotechnology names. REGN ranks #2 (20.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 REGN
Regeneron Pharmaceuticals, Inc.
This page
4,311,806 $3,331,473,778

All Filings in REGN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,331,473,778 4,311,806
2025-12-31 $3,041,291,289 3,940,160
2025-09-30 $2,289,746,729 4,072,326
2025-06-30 $2,068,299,450 3,939,618
2025-03-31 $3,588,598,271 5,658,197
2024-12-31 $5,028,601,731 7,059,371
2024-09-30 $7,873,261,968 7,489,500
2024-06-30 $8,699,706,374 8,277,315
2024-03-31 $7,437,327,694 7,727,174
2023-12-31 $6,347,198,936 7,226,769
2023-09-30 $6,080,978,165 7,389,154
2023-06-30 $4,702,116,410 6,543,987
2023-03-31 $5,212,798,542 6,344,151
2022-12-31 $4,407,975,611 6,109,545
2022-09-30 $3,930,601,969 5,705,869
2022-06-30 $3,356,691,500 5,678,432
2022-03-31 $3,467,632,244 4,964,967
2021-12-31 $2,899,642,386 4,591,529
2021-09-30 $2,482,717,657 4,102,445
2021-06-30 $2,115,969,021 3,788,393
2021-03-31 $1,436,289,799 3,035,655
2020-12-31 $1,118,106,876 2,314,394
2020-09-30 $1,076,655,096 1,923,354
2020-06-30 $1,120,992,158 1,797,470
2020-03-31 $600,310,068 1,229,413